Materials included in Class 31 for use in cat husbandry; litter for cats; materials for sanitary purposes for use by cats; all included in Class 31.;
Domain names similar "MOR"
News around "MOR" trademark
News sentiment analysis powered by sentiment-insight.com
2023-09-06
positive
Is MorphoSys AG (MOR) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
MorphoSys AG (NASDAQ:MOR) recorded a gain of 4.72% in a day and a 3-month increase of 15.11%. With a fair valuation of $18.42, as indicated by its GF Value, the stock appears to be a potential bargain. However, investors need to perform a more in-depth analysis before making an investment decision.
2023-09-05
positive
Is MorphoSys AG (MOR) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap
MorphoSys AG (NASDAQ:MOR) recorded a gain of 4.72% in a day and a 3-month increase of 15.11%. With a fair valuation of $18.42, as indicated by its GF Value, the stock appears to be a potential bargain. However, investors need to perform a more in-depth analysis before making an investment decision.
2023-06-16
positive
Shareholders in MorphoSys (ETR:MOR) have lost 77%, as stock drops 6.9% this past week
MorphoSys AG (ETR:MOR) shareholders will doubtless be very grateful to see the share price up 85% in the last quarter. The last three years have seen a terrible decline. Arguably, the recent bounce is to be expected after such a bad drop. Of course the real question is whether the business can sustain a turnaround.
2023-04-17
positive
MorphoSys AG (ETR:MOR) Stock Catapults 36% Though Its Price And Business Still Lag The Industry
MorphoSys AG (ETR:MOR) shares have had a really impressive month, gaining 36% after a shaky period beforehand. But the share price is still down a very disappointing 21% in the last twelve months. MorphoSys' price-to-sales (or "P/S") ratio of 2.3x might still make it look like a buy right now compared to the Biotechs industry in Germany.
2023-01-07
negative
Investors in MorphoSys (ETR:MOR) have unfortunately lost 90% over the last three years
MorphoSys AG (ETR:MOR) saw its share price tank a massive 90% over a three year period. More recent buyers are having a tough time too, with a drop of 54% in the last year. MorphoSys isn't currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing.
Sign Up
